|
⚲
|
| Keyboard |
| Goldstein Joseph L
✚
|
|
|---|---|
| CIK # | 0001225474 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 4 | [0001225474] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Goldstein Joseph L | |
| Regeneron Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2026-01-02 | Grant | 155 | $0.00 | |
|
Regeneron Pharmaceuticals Inc REGN
Non-Qualified Stock Option (right to buy) · derivative
|
2026-01-02 | Grant | 1,962 | $0.00 | |
|
Regeneron Pharmaceuticals Inc REGN
Non-Qualified Stock Option (right to buy) · derivative
|
2025-01-02 | Grant | 1,958 | $0.00 | |
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2025-01-02 | Grant | 166 | $0.00 | |
|
Regeneron Pharmaceuticals Inc REGN
Non-Qualified Stock Option (right to buy) · derivative
|
2024-01-23 | Option exercise | 2,707 | $0.00 | |
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2024-01-23 | Option exercise | 2,707 | $625.60 | 1,693,499 |
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2024-01-23 | Sell | 2,707 | $950.00 | 2,571,650 |
|
Regeneron Pharmaceuticals Inc REGN
Non-Qualified Stock Option (right to buy) · derivative
|
2024-01-02 | Grant | 1,607 | $0.00 | |
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2024-01-02 | Grant | 135 | $0.00 | |
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2023-02-06 | Option exercise | 3,613 | $482.68 | 1,743,923 |
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2023-02-06 | Sell | 3,613 | $800.00 | 2,890,400 |
|
Regeneron Pharmaceuticals Inc REGN
Non-Qualified Stock Option (right to buy) · derivative
|
2023-02-06 | Option exercise | 3,613 | $0.00 | |
|
Regeneron Pharmaceuticals Inc REGN
Non-Qualified Stock Option (right to buy) · derivative
|
2023-01-03 | Grant | 1,929 | $0.00 | |
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2023-01-03 | Grant | 165 | $0.00 | |
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2022-03-30 | Sell | 2,431 | $700.00 | 1,701,700 |
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2022-03-30 | Option exercise | 2,431 | $374.12 | 909,486 |
|
Regeneron Pharmaceuticals Inc REGN
Non-Qualified Stock Option (right to buy) · derivative
|
2022-03-30 | Option exercise | 2,431 | $0.00 | |
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2022-01-03 | Grant | 191 | $0.00 | |
|
Regeneron Pharmaceuticals Inc REGN
Non-Qualified Stock Option (right to buy) · derivative
|
2022-01-03 | Grant | 2,707 | $0.00 | |
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2021-09-10 | Sell | 2,479 | $650.00 | 1,611,350 |
| showing 20 of 200 most recent transactions | |||||